ICL to Release Q1 2026 Results on May 13
Written by Emily J. Thompson, Senior Investment Analyst
Updated: Apr 22 2026
0mins
Should l Buy ICL?
Source: Newsfilter
- Earnings Release Schedule: ICL plans to release its Q1 2026 results before the TASE market opens on May 13, 2026, with CEO Elad Aharonson and CFO Aviram Lahav hosting a conference call at 8:30 a.m. New York time, demonstrating the company's commitment to transparency and investor communication.
- Participation Details: Financial analysts can dial in using the North American number (833) 461-5787 or the international number (585) 542-9983, with conference ID 273801307, indicating the company's effort to facilitate communication with analysts for enhanced information exchange.
- Webcast Invitation: ICL invites employees, media, and the public to listen to the call via its investor relations website, reflecting the company's commitment to public transparency while providing investors with convenient access to information.
- Company Overview: ICL is a global leader in specialty minerals, with over $7 billion in revenue for 2025, focusing on agriculture, food, and industrial solutions, highlighting its significant role in sustainability and market demand.
Trade with 70% Backtested Accuracy
Stop guessing "Should I Buy ICL?" and start using high-conviction signals backed by rigorous historical data.
Sign up today to access powerful investing tools and make smarter, data-driven decisions.
Analyst Views on ICL
Wall Street analysts forecast ICL stock price to rise
3 Analyst Rating
0 Buy
3 Hold
0 Sell
Hold
Current: 5.430
Low
5.80
Averages
6.18
High
6.75
Current: 5.430
Low
5.80
Averages
6.18
High
6.75
About ICL
ICL Group Ltd, formerly known as Israel Chemicals Ltd, is an Israel-based company, which is engaged in the fertilizer and specialty chemical sectors. The Company operates in three segments: Fertilizers, Industrial Products, and Performance Products. The Fertilizers segment is engaged in the production of standard, granular, fine red and white potash from different sources, as well as in the production of phosphates, such as phosphate rock, phosphoric acid, fertilizers and animal feed addictives. The Industrial Products segment produces flame retardants, such as brominates and organ phosphorus, elemental bromine, and other chemicals. The Performance Products segment produces specialty phosphates, such as technical, food grade and electronic grade phosphoric acid, phosphate salts, food additives and wildfire safety products, as well as alumina and other chemicals.
About the author

Emily J. Thompson
Emily J. Thompson, a Chartered Financial Analyst (CFA) with 12 years in investment research, graduated with honors from the Wharton School. Specializing in industrial and technology stocks, she provides in-depth analysis for Intellectia’s earnings and market brief reports.
- Earnings Release Schedule: ICL plans to release its Q1 2026 results before the TASE market opens on May 13, 2026, with CEO Elad Aharonson and CFO Aviram Lahav hosting a conference call at 8:30 a.m. New York time, demonstrating the company's commitment to transparency and investor communication.
- Participation Details: Financial analysts can dial in using the North American number (833) 461-5787 or the international number (585) 542-9983, with conference ID 273801307, indicating the company's effort to facilitate communication with analysts for enhanced information exchange.
- Webcast Invitation: ICL invites employees, media, and the public to listen to the call via its investor relations website, reflecting the company's commitment to public transparency while providing investors with convenient access to information.
- Company Overview: ICL is a global leader in specialty minerals, with over $7 billion in revenue for 2025, focusing on agriculture, food, and industrial solutions, highlighting its significant role in sustainability and market demand.
See More

- New Facility Launch: ICL's newly opened water soluble fertilizer production facility in Maharashtra, India, spans approximately seven acres and aims to meet the rising fertilizer demand while enhancing supply chain resilience amid the closure of the Strait of Hormuz.
- Market Demand Response: According to customs import data, the Indian water soluble fertilizer market has demonstrated a high single-digit CAGR in recent years, and the new facility will support farmers in increasing yields through efficient fertilizer solutions, thereby strengthening long-term food security.
- Local Production Strategy: The establishment of this facility not only supports the Government of India's 'Make in India' initiative but also reflects ICL's strategy to expand local production in high-growth markets, reducing dependence on cross-border supply chains and ensuring reliable access to agricultural inputs.
- Long-term Investment Returns: ICL anticipates that the facility will reach a production capacity of up to 30,000 tons by 2029, further solidifying its position in the Indian market while creating new employment opportunities and enhancing customer relationships.
See More
- Annual Report Submission: ICL filed its Form 20-F for the fiscal year 2025 with the SEC on March 11, 2026, reporting revenues exceeding $7 billion, indicating sustained growth potential in agriculture, food, and industrial solutions.
- Shareholder Information Access: Shareholders can request free copies of the complete audited financial statements from the Investor Relations department, ensuring transparency and enhancing investor confidence, which fosters a positive relationship between the company and its shareholders.
- Global Business Overview: ICL employs over 12,000 individuals globally, focusing on driving long-term growth through its specialty agriculture and food businesses while effectively managing its bromine, potash, and phosphate mineral resources to address sustainability challenges related to food security and mineral access.
- Risk Factors Advisory: The announcement highlights various potential risks, including the security situation in Israel, market volatility, and environmental regulations, which could impact the company's operations and financial performance, urging investors to carefully assess these risks.
See More
- Executive Change: ICL Group announced the appointment of Asaf Alperovitz as CFO, effective June 15, 2026, succeeding retiring Aviram Lahav, indicating a strategic shift in leadership to support future growth.
- Rich Financial Background: Currently CFO at SolarEdge Technologies, Alperovitz has held CFO roles at Delta Galil Industries and Syneron Candela, bringing extensive financial management experience that will enhance ICL's operational efficiency in future financial strategies.
- Future Outlook: ICL Group targets an EBITDA of $1.4B to $1.6B in 2026, reflecting a proactive stance in advancing specialty growth engines and portfolio realignment, with Alperovitz's expertise expected to facilitate achieving these goals.
- Market Reaction: This executive change may influence investor confidence in ICL's future financial performance, particularly during a critical period of strategic restructuring, where Alperovitz's experience will be vital for the company's stable growth.
See More
- Executive Transition: ICL Group announced that Asaf Alperovitz will succeed Aviram Lahav as Chief Financial Officer on June 15, 2026, marking a significant leadership change aimed at advancing the company's strategic development.
- Leadership Experience: Alperovitz brings over 20 years of financial management experience, having served as CFO at SolarEdge Technologies and held executive roles at several prominent companies, which will provide ICL with new insights and expertise.
- Company Appreciation: ICL President Elad Aharonson expressed gratitude for Lahav's contributions, highlighting his significant role in the company's growth, reflecting the company's commitment to talent and confidence in the future.
- Strategic Outlook: Alperovitz's appointment is seen as a crucial step in executing ICL's growth strategy, expected to enhance the company's business expansion and market competitiveness through his global experience and management skills.
See More

Market Opening: U.S. stock markets are set to open in two hours.
Jazz Pharmaceuticals Performance: Jazz Pharmaceuticals PLC (JAZZ) saw a 10.7% increase in pre-market trading.
Live Nation Entertainment Performance: Live Nation Entertainment Inc. (LYV) experienced an 8.9% rise in pre-market trading.
Overall Market Sentiment: The pre-market gains indicate positive sentiment among investors for these companies.
See More






